Minnesota HF 2004: Prescription drug manufacturer incentive authorized for those importing drugs pursuant to "Pathway 2" of safe importation action plan.

Status: Introduction and first reading, referred to Commerce Finance and Policy (as of 2021-03-08)

State: Minnesota · Session: 2021-2022 · Bill: HF 2004

Subjects: Drugs and Medicine, Health and Health Department

Sponsors: Haley

View Minnesota HF 2004 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.